Subscribe to our Newsletters !!

    Kumar Jeetendra

    Alembic Pharma Gets EIR for API-I & II Facility at Panelav

    Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug Administration (USFDA) at its API-I and API-II facilities in Panelav. The inspection was carried out between May 26, 2025 and May 31, 2025. About Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited, a vertically integrated research and

    Jodi Barrientos on Leading Synthetic Biology’s Next Wave

    Microbioz India recently hosted a podcast in which Jodi Barrientos, CEO of Ribbon Bio, very eloquently described her career path, her thoughts on the future of synthetic bio, and the change(s) she hopes to implement in our industry. Jodi Barrientos spent 17 years in the commercial sector, exceeding the expectations of some of the world’s

    Pharma 2030: AI, Automation & The Next Era of Drug Development

    For the first time in its chronicle, the pharmaceutical industry is on the verge of crossing a transformative threshold. The next decade and a half will not focus on the completion of incremental improvements but on the determining of a new paradigm in the intricate relationship of science and technology. The paradigm will focus on

    Are You Accounting for These Stability Risks in Drug Formulation?

    Within the broader context of the pharmaceutical industry’s drug development trajectory, the drug’s stability goes beyond being a quality measure; it influences safety, effective marketing, and compliance with governmental regulations. Pharmaceutical companies undergo strict quality control measures, and any lapse in a drug product’s stability profile during development, storage, or shipment would render any and

    From Bench to Breakthrough Modernizing Analytical Testing in Pharma

    Analytical testing remains foundational to pharmaceutical innovation, guaranteeing the safety, efficacy, and dependability of every pill, vial, and biologic sent to patients. Yet the industry’s increasing focus on complex biologics, personalized medicine, and accelerated development cycles suggests the need for innovative approaches to analysis. The industry must embrace innovation for modernization, including advanced technologies, automation,

    Alembic & Amlan Launch MinerTox-Z and MinerTox-A

    Alembic Pharmaceuticals Ltd., through a strategic agreement with Amlan International, today announced the India launch of MinerTox-Z and MinerTox-A, feed additive solutions developed to protect poultry against toxins and enhance farm productivity. The introduction of these products represents an important step in addressing one of the poultry industry’s most pressing challenges—losses caused by toxins. By

    Breakthroughs Behind the 2025 Nobel Prize in Medicine

    The Nobel Prize in Physiology or Medicine awarded in 2025 expressed yet again the value of modern medical research. This year the prize commends the deep accomplishments in our understanding of the human immune system. The prize goes to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking discoveries for the understanding of

    Temperature Control Perfected: Inside the JULABO PURA Water Bath

    The JULABO PURA series is a modern line of laboratory water baths designed for precision, safety, and ease of use. These units are made to support a range of temperature-controlled tasks—routine or demanding—while offering durability and intuitive operation. Their temperature range (usually from ~ +25°C up to ~ +99.9 °C) makes them suitable for many

    Single-Use Technologies in Biologics Manufacturing: Benefits, Challenges, and Growing Demand

    The increasing adoption of single-use technologies (SUT) in the biopharmaceutical industry is largely due to the added flexibility and cost reduction along with shortened marginal development times provided by SUT innovations. Unlike stainless steel systems SUTs virtually devoid of capital investments and also eliminate labor intensive cleaning and sterilization, while also containing the risk of

    XPR Automatic Balance: Revolutionizing Pharmaceutical Weighing with Precision, Safety, and Efficiency

    In the highly regulated and precision-driven pharmaceutical industry, accurate weighing of powders and liquids is critical for ensuring product quality, compliance, and safety. The XPR Automatic Balance from METTLER TOLEDO offers an advanced automated solution designed to meet these stringent demands, providing unparalleled accuracy, efficiency, and user protection. Applications in the Pharmaceutical Industry The XPR

    Eppendorf Expands Sustainable Lab Line with BioBased Deepwell Plates

    Eppendorf is proud to announce the launch of its Deepwell Plates BioBased, made from min. 95 % second-generation feedstock (according to mass-balance-approach*). This innovative product represents a significant step forward in sustainable laboratory practices, aligning with Eppendorf’s commitment to environmental stewardship and scientific advancement. The new Deepwell Plates BioBased are designed to meet highest standards